Sort   by:  
 Page size 
GenomicsSGDAC- SciGenom Data Access Committee
Data Access Committee EGAC00001000077
EGAC00001000077 | EGA
UnknownDistribution of antibiotic resistance and virulence factors among the bacteria isolated from diseased Etroplus suratensis.
Not available
S-EPMC6419682 | biostudies-literature
UnknownPatient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
Not available
S-EPMC5834154 | biostudies-literature
ProteomicsIdentifying interactors of IRF1 and STAT1 during type I and type II interferon treatment using proximity-dependent labeling
Identifying interactors of IRF1 and STAT1 in bone marrow-derived macrophages during type I and type II interferon treatment using the proximity-dependent labeling approach TurboID followed by Mass Spectrometry
ORGANISM(S): Mus musculus (Mouse) 
2024-03-12 | PXD040337 | Pride
Turboid Interactors Irf1 Ifn-ii Ifn-i Stat1 
TranscriptomicsSilencing of microRNAs in mouse liver with "antagomirs
Using a novel class of chemically-engineered oligonucleotides, termed "antagomirs", we studied the biological significance of silencing miR-122 in the liver of mice at the mRNA level Experiment Overall Design: Mice were injected on three subsequent days with antagomir-122 or scrambled control (mm-an...
ORGANISM(S): Mus musculus 
2008-06-12 | E-GEOD-3425 | biostudies-arrayexpress
UnknownIdentification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.
Not available
S-EPMC427845 | biostudies-literature
UnknownPhase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
Not available
S-EPMC4658453 | biostudies-literature
UnknownOutcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Not available
S-EPMC5698336 | biostudies-literature
UnknownTen simple rules to host an inclusive conference.
Not available
S-EPMC9302732 | biostudies-literature
ProteomicsProteomic analysis of Angelman mouse models
Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of neuronal E3 ligase UBE3A. Restoring UBE3A levels is a potential disease-modifying therapy for AS and has recently entered clinical trials. There is paucity of data regarding the molecular changes downstream of UBE3A...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2021-08-12 | MSV000087972 | MassIVE
Sort   by:  
 Page size